High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression

Antiviral Therapy

Volumn 16, Issue 8, 2011, Pages 1351-1355

  Kanjanavanit, Suparat ^a   Puthanakit, Thanyawee ^b,c   Vibol, Ung ^d   Kosalaraksa, Pope ^e   Hansudewechakul, Rawiwan ^f   Ngampiyasakul, Chaiwat ^g   Wongsawat, Jurai ^h   Luesomboon, Wicharn ⁱ   Wongsabut, Jiratchaya ^b   Mahanontharit, Apicha ^b   Suwanlerk, Tulathip ^b   Saphonn, Vonthanak ^j   Ananworanich, Jintanat ^b,c,k   Ruxrungtham, Kiat ^b,c  

^a NAKORNPING HOSPITAL   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d National Pediatric Hospital   (Cambodia)

^e KHON KAEN UNIVERSITY   (Thailand)

^f Chiang Rai Prachanukhro Hospital   (Thailand)

^g PRAPOKKLAO HOSPITAL   (Thailand)

^h Bamrasnaradura Infectious Diseases Institute   (Thailand)

ⁱ Queen Savang Vadhana Memorial Hospital   (Thailand)

^j National Center for HIV/AIDS   (Cambodia)

^k South East Asia Research Collaboration with Hawaii ^*  (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VIRUS RNA;

ARTICLE; ASIAN; BODY WEIGHT; CAMBODIA; CD4 LYMPHOCYTE COUNT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; THAILAND; VIRUS GENE;

ANTIGENS, CD4; CAMBODIA; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PREVALENCE; RNA, VIRAL; THAILAND; TRIGLYCERIDES; VIRAL LOAD;

EID: 83455200007     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1897     Document Type: Article

References (21)

1. Aldrovandi GM, Lindsey JC, Jacobson DL, et al. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS 2009; 23:661-672.
2. Chantry CJ, Hughes MD, Alvero C, et al. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics 2008; 122:e129-e138.
3. Carter RJ, Wiener J, Abrams EJ, et al. Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis. J Acquir Immune Defic Syndr 2006; 41:453-460.
4. Farley J, Gona P, Crain M, et al. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr 2005; 38:480-487. (Pubitemid 40381558)
5. Grunfeld C, Kotler DP, Hamadeh R, et al. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989; 86:27-31.
6. Grunfeld C, Pang M, Doerrler W, et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74:1045-1052.
7. Grunfeld C, Tien P. Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome. Clin Infect Dis 2003; 37 Suppl 2:S43-S46. (Pubitemid 37102723)
8. El-Sadr WM, Mullin CM, Carr A, et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med 2005; 6:114-121. (Pubitemid 40425975)
9. Friis-Møller N, Reiss P, El-Sadr W, et al. Exposure to PI and NNRTI and risk of myocardial infarction: results from the D:A:D study. 13th Conference on Retroviruses and Opportunistic Infections. 5-8 February 2006, Denver, CO, USA. Abstract 144.
10. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296.
11. McComsey GA, O'Riordan M, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007; 21:921-927. (Pubitemid 46684323)
12. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89:495-501.
13. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106:3143-3421.
14. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115:1948-1967. (Pubitemid 46598908)
15. Cervia JS, Chantry CJ, Hughes MD, et al. Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy. Pediatr Infect Dis J 2010; 29:1118-1122.
16. Aurpibul L, Puthanakit T, Lee B, et al. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther 2007; 12:1247-1254.
17. Botton J, Heude B, Kettaneh A, et al. Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: the Fleurbaix Laventie Ville Sante II study. Metabolism 2007; 56:614-622. (Pubitemid 46591894)
18. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23:381-389.
19. Raghavan S, Chen L, El-Sadr W, et al. Prevalence and factors associated with fasting hypercholesterolemia, hypertriglyceridemia, and hyperglycemia in ethnically diverse antiretroviral naive patients (CPCRA 058). XIII International AIDS Conference. 9-14 July 2000, Durban, South Africa. Abstract WePeB4269.
20. Rose H, Woolley I, Hoy J, et al. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism 2006; 55:90-95. (Pubitemid 41736252)
21. Calmy A, Gayet-Ageron A, Montecucco F, et al. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS 2009; 23:929-939.